[Federal Register Volume 64, Number 37 (Thursday, February 25, 1999)]
[Notices]
[Page 9344]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-4652]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel Tuberculosis Drug Development:
Tuberculosis Anti-microbial Acquisition and Coordinating Facility.
Date: March 23, 1999.
Time: 11:00 AM to 1:00 PM.
Agenda: To review and evaluate contract proposals.
Place: Solar Building, Room 4C-05, 6003 Executive Blvd.,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Allen C. Stoolmiller, PHD, Scientific Review
Administrator, Scientific Review Program, Division of Extramural
Activities, NIAID, NIH, Solar Building, Room 4C05, 6003 Executive
Boulevard MSC 7610, Bethesda, MD 20892-7610, 301-496-7966.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.956,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: February 19, 1999.
Anna Snouffer,
Acting Committee Management Officer, NIH.
[FR Doc. 99-4652 Filed 2-24-99; 8:45 am]
BILLING CODE 4140-01-M